+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket

Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket

Journal of Biological Chemistry 287(52): 43694-43707

The serotonin transporter (SERT) and the norepinephrine transporter (NET) are sodium-dependent neurotransmitter transporters responsible for reuptake of released serotonin and norepinephrine, respectively, into nerve terminals in the brain. A wide range of inhibitors of SERT and NET are used as treatment of depression and anxiety disorders or as psychostimulant drugs of abuse. Despite their clinical importance, the molecular mechanisms by which various types of antidepressant drugs bind and inhibit SERT and NET are still elusive for the majority of the inhibitors, including the molecular basis for SERT/NET selectivity. Mutational analyses have suggested that a central substrate binding site (denoted the S1 pocket) also harbors an inhibitor binding site. In this study, we determine the effect of mutating six key S1 residues in human SERT (hSERT) and NET (hNET) on the potency of 15 prototypical SERT/NET inhibitors belonging to different drug classes. Analysis of the resulting drug sensitivity profiles provides novel information on drug binding modes in hSERT and hNET and identifies specific S1 residues as important molecular determinants for inhibitor potency and hSERT/hNET selectivity.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 053903807

Download citation: RISBibTeXText

PMID: 23086945

DOI: 10.1074/jbc.m112.342212

Related references

Norepinephrine and serotonin transporters Progress on molecular targets of antidepressants. Watson, S J Biology of schizophrenia and affective disease 49-81, 1996

A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biological Psychiatry 59(5): 408-414, 2005

Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters. Proceedings of the National Academy of Sciences of the United States of America 108(29): 12137-12142, 2011

The antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters. Leukemia and Lymphoma 51(3): 523-539, 2010

Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters. Journal of Medicinal Chemistry 46(25): 5512-5532, 2003

In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain. Neurochemical Research 33(11): 2250-2256, 2008

Ion dependence of substrate binding in norepinephrine transporters. Biophysical Journal 86(1): 555a-556a, 2004

Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters. Chemical Communications 2009(25): 3677-3692, 2009

What Contributes to Serotonin-Norepinephrine Reuptake Inhibitors' Dual-Targeting Mechanism? The Key Role of Transmembrane Domain 6 in Human Serotonin and Norepinephrine Transporters Revealed by Molecular Dynamics Simulation. Acs Chemical Neuroscience 9(5): 1128-1140, 2018

Simultaneous Multiple MS Binding Assays for the Dopamine, Norepinephrine, and Serotonin Transporters. Chemmedchem 13(5): 453-463, 2018

Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29(2): 297-303, 2005

Mutational analysis of the primary substrate specificity pocket of complement factor B. Asp(226) is a major structural determinant for p(1)-Arg binding. Journal of Biological Chemistry 275(1): 378-385, 2000

Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sciences 46(9): 635-645, 1990

Influence of ligand binding kinetics on functional inhibition of human recombinant serotonin and norepinephrine transporters. Journal of Pharmacological and Toxicological Methods 61(2): 192-204, 2010

Modelling and mutational evidence identify the substrate binding site and functional elements in APC amino acid transporters. Molecular Membrane Biology 26(5): 356-370, 2009